Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets

• Status: Completed
• Trial end date: 2014-02-01

Summary

The purpose of this study is to measure the in-vivo disintegration time of a single dexlansoprazole delayed-release orally disintegrating (OD) tablet.

• Phase: Phase 1

Details

• Lead Sponsor: Takeda
• Treatments: Dexlansoprazole; Lansoprazole